Xi Chen Lin
Fortune : 702 463 $ au 31/05/2026
Fortune : 702 463 $ au 31/05/2026
Xi Chen Lin is currently Chief Scientific Officer & GM-Structure Shanghai at Structure Therapeutics, Inc. since 2019 and General Manager at Shanghai ShouTi Biotechnology Co. Ltd. Formerly, Dr. Lin was Head-Asia Pacific External Innovation at Novo Nordisk A from 2016 to 2019.
Education includes undergraduate studies at Peking University and a doctorate from The Pennsylvania State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 53 574 ( 0,04 % ) | 702 463 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/07/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national